| Patent | Date |
|---|
Bispecific Binding Molecules
App 20220306740 - Chervin; Adam S. ; et al. | 2022-09-29 |
PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHY- L)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF
App 20220306643 - Pangan; Aileen L. ; et al. | 2022-09-29 |
PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2- -TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF
App 20220298166 - Pangan; Aileen L. ; et al. | 2022-09-22 |
PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2- -TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF
App 20220298165 - Othman; Ahmed A. ; et al. | 2022-09-22 |
Methods for Treating HCV
App 20220288153 - Awni; Walid M. ; et al. | 2022-09-15 |
Anti-egfr Antibodies And Antibody Drug Conjugates
App 20220288221 - REILLY; Edward B. ; et al. | 2022-09-15 |
Anti-cd40 Antibodies And Uses Thereof
App 20220289858 - Benatuil; Lorenzo ; et al. | 2022-09-15 |
PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2- -TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF
App 20220281882 - Allian; Ayman ; et al. | 2022-09-08 |
Methods Of Treatment Of Diseases In Which Il-13 Activity Is Detrimental Using Anti-il-13 Antibodies
App 20220281968 - Timony; Gregg ; et al. | 2022-09-08 |
Methods Of Treating Crohn's Disease And Ulcerative Colitis
App 20220273651 - Pangan; Aileen L. ; et al. | 2022-09-01 |
PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2- -TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF
App 20220267342 - Allian; Ayman ; et al. | 2022-08-25 |
Anti-cd40 Antibody Drug Conjugates
App 20220265842 - Hobson; Adrian D. ; et al. | 2022-08-25 |
Medication Packaging And Dispensing System
App 20220267073 - Kim; Lori ; et al. | 2022-08-25 |
Combination Therapy Of A Type Ii Anti-cd20 Antibody With A Selective Bcl-2 Inhibitor
App 20220265642 - Sampath; Deepak ; et al. | 2022-08-25 |
Methods of Administering Elagolix
App 20220257597 - Shebley; Mohamad ; et al. | 2022-08-18 |
Macrocyclic Mcl-1 Inhibitors And Methods Of Use
App 20220259226 - Braje; Wilfried ; et al. | 2022-08-18 |
Methods Of Treating Crohn's Disease And Ulcerative Colitis
App 20220259301 - Wallace; Kori ; et al. | 2022-08-18 |
Combination therapy of a type II anti-CD20 antibody with a selective BCL-2 inhibitor
Grant 11,413,282 - Sampath , et al. August 16, 2 | 2022-08-16 |
Prodrug Modulators Of The Integrated Stress Pathway
App 20220251123 - Martin; Kathleen Ann ; et al. | 2022-08-11 |
PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2- -TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF
App 20220251101 - ALLIAN; Ayman ; et al. | 2022-08-11 |
Methods Of Treating Crohn's Disease And Ulcerative Colitis
App 20220233527 - Machado De Lacerda; Ana Paula ; et al. | 2022-07-28 |
Anti-EGFR Antibody-Drug Conjugates
App 20220226494 - Boghaert; Erwin R. ; et al. | 2022-07-21 |
Isolation and purification of anti-IL-13 antibodies using protein a affinity chromatography
Grant 11,390,668 - Hickman July 19, 2 | 2022-07-19 |
Methods of treatment of diseases in which IL-13 activity is detrimental using anti-IL-13 antibodies
Grant 11,390,669 - Timony , et al. July 19, 2 | 2022-07-19 |
Combination Therapy Of A Type Ii Anti-cd20 Antibody With A Selective Bcl-2 Inhibitor
App 20220211696 - Sampath; Deepak ; et al. | 2022-07-07 |
Bicyclic Pyrazole Bruton's Tyrosine Kinase Inhibitors
App 20220213092 - DeGoey; David A. ; et al. | 2022-07-07 |
Enzyme Compositions With Reduced Viral And Microbial Contamination
App 20220211825 - Babcock; Martin ; et al. | 2022-07-07 |
Melt-extruded solid dispersions containing an apoptosis-inducing agent
Grant 11,369,599 - Birtalan , et al. June 28, 2 | 2022-06-28 |
Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2- -trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
Grant 11,365,198 - Mohamed , et al. June 21, 2 | 2022-06-21 |
Sleeve container
Grant D954,563 - Upchurch , et al. June 14, 2 | 2022-06-14 |
Medication packaging and dispensing system
Grant 11,358,773 - Kim , et al. June 14, 2 | 2022-06-14 |
Methods of treating heavy menstrual bleeding
Grant 11,344,551 - Chwalisz , et al. May 31, 2 | 2022-05-31 |
Interleukin-13 binding proteins
Grant 11,344,621 - Wu , et al. May 31, 2 | 2022-05-31 |
Methods Of Treating Parkinson's Disease
App 20220153765 - Cardinal-David; Benoit ; et al. | 2022-05-19 |
Sleeve container
Grant D951,778 - Upchurch , et al. May 17, 2 | 2022-05-17 |
Solid Dispersions Containing An Apoptosis-inducing Agent
App 20220125796 - Catron; Nathaniel ; et al. | 2022-04-28 |
Organic reactions carried out in aqueous solution in the presence of a hydroxyalkyl(alkyl)cellulose or an alkylcellulose
Grant 11,312,668 - Braje , et al. April 26, 2 | 2022-04-26 |
Modulators Of The Integrated Stress Pathway
App 20220106281 - Sidrauski; Carmela ; et al. | 2022-04-07 |
Dosing regimens for use in treating myelofibrosis and MPN-related disorders with navitoclax
Grant 11,285,159 - Hayslip , et al. March 29, 2 | 2022-03-29 |
Automatic Injection Device
App 20220088309 - Shang; Sherwin S. ; et al. | 2022-03-24 |
Enzyme compositions with reduced viral and microbial contamination
Grant 11,278,603 - Babcock , et al. March 22, 2 | 2022-03-22 |
Methods Of Treating Heavy Menstrual Bleeding
App 20220079945 - Chwalisz; Kristof ; et al. | 2022-03-17 |
2,2-difluoropropionamide Derivatives Of Bardoxolone Methyl, Polymorphic Forms And Methods Of Use Thereof
App 20220073559 - SHEIKH; Ahmad Y. ; et al. | 2022-03-10 |
PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2- -TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF
App 20220073530 - ALLIAN; Ayman ; et al. | 2022-03-10 |
Solid pharmaceutical compositions for treating HCV
Grant 11,246,866 - Sever , et al. February 15, 2 | 2022-02-15 |
Crystal forms
Grant RE48,923 - Califano , et al. February 8, 2 | 2022-02-08 |
Wearable Automatic Injection Device For Controlled Administration Of Therapeutic Agents
App 20220023544 - Anderson; Philip D. ; et al. | 2022-01-27 |
Methods For Treating Spinal Cord Injury And Pain
App 20220025031 - MUELLER; Bernhard Klaus ; et al. | 2022-01-27 |
Monoclonal Antibodies Against Amyloid Beta Protein And Uses Thereof
App 20220017607 - HILLEN; Heinz ; et al. | 2022-01-20 |
Bromodomain Inhibitors
App 20220017511 - Fidanze; Steven D. ; et al. | 2022-01-20 |
Anti-alpha-4-beta-7 Antibodies
App 20220017624 - Min; Jing ; et al. | 2022-01-20 |
Medicine Container, Method Of Assembling The Container, And Method Of Dispensing The Medicine From The Container
App 20220008290 - Marshall; Todd ; et al. | 2022-01-13 |
Combination Therapy Of A Type Ii Anti-cd20 Antibody With A Selective Bcl-2 Inhibitor
App 20220008413 - Sampath; Deepak ; et al. | 2022-01-13 |
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20210403467 - Tao; Zhi-Fu ; et al. | 2021-12-30 |
Modulators Of The Integrated Stress Pathway
App 20210393599 - Martin; Kathleen Ann ; et al. | 2021-12-23 |
Methods of Treating Acute HCV
App 20210386735 - Matthews; Gail ; et al. | 2021-12-16 |
Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2- -trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
Grant 11,198,697 - Allian , et al. December 14, 2 | 2021-12-14 |
Syringe With Two-stage Sealing Pressure
App 20210379290 - Mackey; Sean E. ; et al. | 2021-12-09 |
Methods Of Treatment Of Diseases In Which Il-13 Activity Is Detrimental Using Anti-il-13 Antibodies
App 20210380674 - TIMONY; Gregg ; et al. | 2021-12-09 |
Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2- -trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
Grant 11,186,584 - Allian , et al. November 30, 2 | 2021-11-30 |
Modulators Of The Integrated Stress Pathway
App 20210363136 - Martin; Kathleen Ann ; et al. | 2021-11-25 |
PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2- -TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF
App 20210363149 - ALLIAN; Ayman ; et al. | 2021-11-25 |
Methods Of Treating Crohn's Disease And Ulcerative Colitis
App 20210361647 - Thakkar; Roopal B. ; et al. | 2021-11-25 |
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20210346369 - WANG; Le ; et al. | 2021-11-11 |
Prodrug modulators of the integrated stress pathway
Grant 11,149,043 - Dart , et al. October 19, 2 | 2021-10-19 |
Dosing Regimens for Elagolix
App 20210308135 - Shebley; Mohamad | 2021-10-07 |
PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2- -TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF
App 20210309667 - ALLIAN; Ayman ; et al. | 2021-10-07 |
Prolactin Receptor Binding Proteins And Uses Thereof
App 20210312797 - Anderson; Mark ; et al. | 2021-10-07 |
Macrocyclic Mcl-1 Inhibitors And Methods Of Use
App 20210292339 - BRAJE; Wilfried ; et al. | 2021-09-23 |
Child-resistant medication container
Grant D930,974 - Marshall , et al. September 21, 2 | 2021-09-21 |
Child-resistant medication container
Grant D930,973 - Marshall , et al. September 21, 2 | 2021-09-21 |
2,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof
Grant 11,117,927 - Sheikh , et al. September 14, 2 | 2021-09-14 |
Methods of Administering Elagolix
App 20210275527 - Ali; Farah N. ; et al. | 2021-09-09 |
Methods Of Treating Heavy Menstrual Bleeding
App 20210275528 - Chwalisz; Kristof ; et al. | 2021-09-09 |
Combination therapy of a type II anti-CD20 antibody with a selective Bcl-2 inhibitor
Grant 11,110,087 - Sampath , et al. September 7, 2 | 2021-09-07 |
Modulators Of The Integrated Stress Pathway
App 20210269399 - Sidrauski; Carmela ; et al. | 2021-09-02 |
Bromodomain Inhibitors
App 20210253551 - Bogdan; Andrew ; et al. | 2021-08-19 |
Bispecific Binding Molecules
App 20210253700 - Chervin; Adam S. ; et al. | 2021-08-19 |
Methods of treating Parkinson's disease
Grant 11,091,507 - Enright , et al. August 17, 2 | 2021-08-17 |
Composition And Method For The Diagnosis And Treatment Of Diseases Associated With Neurite Degeneration
App 20210238270 - Mueller; Bernhard ; et al. | 2021-08-05 |
Bromodomain Inhibitors
App 20210236508 - Wang; Le ; et al. | 2021-08-05 |
Antibodies Against The Rgm A Protein And Uses Thereof
App 20210230260 - Mueller; Bernhard K. ; et al. | 2021-07-29 |
Medicine Container, Method of Assembling the Container, and Method of Manufacturing the Container
App 20210228442 - Medhal; Bhimaprasad ; et al. | 2021-07-29 |
Treating Spondyloarthritic And Psoriatic Conditions With Upadacitinib
App 20210228575 - Pangan; Aileen L. ; et al. | 2021-07-29 |
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20210228565 - Wang; Le ; et al. | 2021-07-29 |
Prodrug Modulators Of The Integrated Stress Pathway
App 20210230195 - Martin; Kathleen Ann ; et al. | 2021-07-29 |
Apoptosis Inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20210221789 - Bruncko; Milan ; et al. | 2021-07-22 |
Modulators Of The Integrated Stress Pathway
App 20210205277 - Martin; Kathleen Ann ; et al. | 2021-07-08 |
Medicine container, method of assembling the container, and method of dispensing the medicine from the container
Grant 11,052,021 - Marshall , et al. July 6, 2 | 2021-07-06 |
Methods of treating heavy menstrual bleeding
Grant 11,045,470 - Chwalisz , et al. June 29, 2 | 2021-06-29 |
Anti-huLRRC15 antibody drug conjugates and methods for their use
Grant 11,045,480 - Gish , et al. June 29, 2 | 2021-06-29 |
Primary Carboxamides As Btk Inhibitors
App 20210179556 - Bonafoux; Dominique ; et al. | 2021-06-17 |
Combination Therapy Of A Type Ii Anti-cd20 Antibody With A Selective Bcl-2 Inhibitor
App 20210177838 - Sampath; Deepak ; et al. | 2021-06-17 |
Anti-b7-h3 Antibodies And Antibody Drug Conjugates
App 20210171637 - Benatuil; Lorenzo ; et al. | 2021-06-10 |
Process for Manufacturing Pibrentasvir Active Drug Substance
App 20210171506 - Hillier; Michael ; et al. | 2021-06-10 |
Modulators Of The Integrated Stress Pathway
App 20210171508 - Martin; Kathleen Ann ; et al. | 2021-06-10 |
Modulators Of The Integrated Stress Pathway
App 20210169892 - Martin; Kathleen Ann ; et al. | 2021-06-10 |
Methods of Treating Heavy Menstrual Bleeding
App 20210154207 - Chwalisz; Kristof ; et al. | 2021-05-27 |
Composition And Method For The Diagnosis And Treatment Of Iron-related Disorders
App 20210155681 - Mueller; Bernhard ; et al. | 2021-05-27 |
Anti-cd71 Activatable Antibody Drug Conjugates And Methods Of Use Thereof
App 20210145978 - Singh; Shweta ; et al. | 2021-05-20 |
Sleeve Containers For Packaging Medicinal Products
App 20210139190 - Upchurch; Guy C. ; et al. | 2021-05-13 |
Bromodomain Inhibitors
App 20210130346 - Hardee; David ; et al. | 2021-05-06 |
Dosing Regimens For Use In Treating Myelofibrosis And Mpn-related Disorders With Navitoclax
App 20210128573 - Hayslip; John ; et al. | 2021-05-06 |
Spiro-cyclic Amine Derivatives As S1p Modulators
App 20210130364 - Stoit; Axel ; et al. | 2021-05-06 |
Nuclear Receptor Modulators
App 20210130293 - Argiriadi; Maria A. ; et al. | 2021-05-06 |
Combination therapy of a type II anti-CD20 antibody with a selective BCL-2 inhibitor
Grant 10,993,942 - Sampath , et al. May 4, 2 | 2021-05-04 |
Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2- -trifluoroethyl)pyrrolidine-1-carb oxamide and solid state forms thereof
Grant 10,995,095 - Pangan , et al. May 4, 2 | 2021-05-04 |
Modulators Of The Integrated Stress Pathway
App 20210113532 - Sidrauski; Carmela ; et al. | 2021-04-22 |
Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2- -trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
Grant 10,981,924 - Jayanth , et al. April 20, 2 | 2021-04-20 |
Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[l,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2- -trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
Grant 10,981,923 - Allian , et al. April 20, 2 | 2021-04-20 |
Enzymatic Processes For The Preparation Of (.+-.)-2-(difluoromethyl)-1-(alkoxycarbonyl)-cyclopropanecarboxylic Acid And (.+-.)-2-(vinyl)-1-(alkoxycarbonyl)-cyclopropanecarboxylic Acid
App 20210087592 - Abrahamson; Michael J. ; et al. | 2021-03-25 |
Protein tyrosine phosphatase inhibitors and methods of use thereof
Grant 10,954,202 - Xiong , et al. March 23, 2 | 2021-03-23 |
Tetracyclic Bromodomain Inhibitors
App 20210070756 - Fidanze; Steven D. ; et al. | 2021-03-11 |
Prolactin Receptor Binding Proteins And Uses Thereof
App 20210074147 - Anderson; Mark ; et al. | 2021-03-11 |
Levodopa And Carbidopa Intestinal Gel And Methods Of Use
App 20210059968 - DEAC; Alexandru ; et al. | 2021-03-04 |
Novel Tricyclic Compounds
App 20210061813 - WISHART; Neil ; et al. | 2021-03-04 |
Anti-prlr Antibody-drug Conjugates (adc) And Uses Thereof
App 20210061916 - Reilly; Edward B. ; et al. | 2021-03-04 |
Bromodomain Inhibitors
App 20210047304 - Cowart; Marlon ; et al. | 2021-02-18 |
Levodopa And Carbidopa Intestinal Gel And Methods Of Use
App 20210046029 - CONJEEVARAM; Rajkumar ; et al. | 2021-02-18 |
Methods and compositions for treating asthma using anti-IL-13 antibodies
Grant 10,919,961 - Tripp February 16, 2 | 2021-02-16 |
Single-Chain Trail-Receptor Agonist Proteins
App 20210040178 - Buchanan; Fritz G. ; et al. | 2021-02-11 |
Systems And Methods For Identifying Protein Aggregates In Biotherapeutics
App 20210041337 - Matayoshi; Edmund ; et al. | 2021-02-11 |
Modulators of the integrated stress pathway
Grant 10,913,727 - Pliushchev , et al. February 9, 2 | 2021-02-09 |
Electronic Pill Dispenser and Related Methods of Use
App 20210030626 - Medhal; Bhimaprasad | 2021-02-04 |
Solid Pharmaceutical Compositions for Treating HCV
App 20210023012 - Liu; Wei ; et al. | 2021-01-28 |
Ectonucleotide Pyrophosphate-phosphodiesterase (enpp) Conjugates And Uses Thereof
App 20210023234 - GALLATIN; William Michael ; et al. | 2021-01-28 |
Organic Reactions Carried Out In Aqueous Solution In The Presence Of A Hydroxyalkyl(alkyl)cellulose Or An Alkylcellulose
App 20210017100 - BRAJE; Wilfried ; et al. | 2021-01-21 |
Selective Reduction Of Antibodies
App 20210017222 - Haight; Anthony R ; et al. | 2021-01-21 |
Glucocorticoid Receptor Agonist And Immunoconjugates Thereof
App 20210015938 - Hobson; Adrian D. ; et al. | 2021-01-21 |
Therapeutic DLL4 Binding Proteins
App 20210009681 - Chen; Ming-Jiu ; et al. | 2021-01-14 |
Protein Tyrosine Phosphatase Inhibitors And Methods Of Use Thereof
App 20210009542 - Xiong; Zhaoming ; et al. | 2021-01-14 |
Methods of treating heavy menstrual bleeding
Grant 10,881,659 - Chwalisz , et al. January 5, 2 | 2021-01-05 |
Anti-egfr Antibodies And Antibody Drug Conjugates
App 20200405878 - Reilly; Edward B. ; et al. | 2020-12-31 |
Modulators of the integrated stress pathway
Grant 10,864,196 - Pliushchev , et al. December 15, 2 | 2020-12-15 |
High purity oritavancin and method of producing same
Grant 10,864,249 - Rafai Far , et al. December 15, 2 | 2020-12-15 |
PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2- -TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF
App 20200385393 - Pangan; Aileen L. ; et al. | 2020-12-10 |
Stable Dual Variable Domain Immunoglobulin Protein Formulations
App 20200385456 - Siedler; Michael ; et al. | 2020-12-10 |
Automatic injection device
Grant 10,857,302 - Shang , et al. December 8, 2 | 2020-12-08 |
Protein tyrosine phosphatase inhibitors and methods of use thereof
Grant 10,851,073 - Halvorsen , et al. December 1, 2 | 2020-12-01 |
Methods for Treating HCV
App 20200368229 - Collins; Christine ; et al. | 2020-11-26 |
Methods of Treating Glioblastoma
App 20200368525 - MAAG; David ; et al. | 2020-11-26 |
Modulators Of The Integrated Stress Pathway
App 20200361941 - Martin; Kathleen Ann ; et al. | 2020-11-19 |
PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2- -TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF
App 20200361949 - Jayanth; Jayanthy ; et al. | 2020-11-19 |
Salts And Crystalline Forms Of An Apoptosis-inducing Agent
App 20200361932 - Catron; Nathaniel ; et al. | 2020-11-19 |
Modulators Of The Integrated Stress Pathway
App 20200361881 - Martin; Kathleen Ann ; et al. | 2020-11-19 |
Modulators of the integrated stress pathway
Grant 10,836,725 - Pliushchev , et al. November 17, 2 | 2020-11-17 |
Organic reactions carried out in aqueous solution in the presence of a hydroxyalkyl(alkyl)cellulose or an alkylcellulose
Grant 10,836,688 - Braje , et al. November 17, 2 | 2020-11-17 |
Fused heterocyclic derivatives as S1P modulators
Grant RE48,301 - Smid , et al. November 10, 2 | 2020-11-10 |
Methods For Treating Spinal Cord Injury And Pain
App 20200347123 - MUELLER; Bernhard Klaus ; et al. | 2020-11-05 |
Modulators Of The Integrated Stress Pathway
App 20200347043 - Martin; Kathleen Ann ; et al. | 2020-11-05 |
Modulators Of The Integrated Stress Pathway
App 20200345727 - Martin; Kathleen Ann ; et al. | 2020-11-05 |
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20200345717 - WANG; Le ; et al. | 2020-11-05 |
Medication Packaging And Dispensing System
App 20200346830 - Kim; Lori ; et al. | 2020-11-05 |
Modulators Of The Integrated Stress Pathway
App 20200347033 - Martin; Kathleen Ann ; et al. | 2020-11-05 |
Composition and method for the diagnosis and treatment of iron-related disorders
Grant 10,822,403 - Mueller , et al. November 3, 2 | 2020-11-03 |
Glucocorticoid Receptor Agonist And Immunoconjugates Thereof
App 20200338208 - McPherson; Michael J. ; et al. | 2020-10-29 |
Anti-b7-h3 Antibodies And Antibody Drug Conjugates
App 20200338209 - Benatuil; Lorenzo ; et al. | 2020-10-29 |
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20200331907 - Tao; Zhi-Fu ; et al. | 2020-10-22 |
Methods for Treating HCV
App 20200330460 - Collins; Christine ; et al. | 2020-10-22 |
Spiro-cyclic amine derivatives as S1P modulators
Grant 10,807,991 - Stoit , et al. October 20, 2 | 2020-10-20 |
Systems and methods for tubing delivery
Grant 10,806,679 - Babbs , et al. October 20, 2 | 2020-10-20 |
Macrocyclic MCL-1 Inhibitors and Methods of Use
App 20200325153 - Judd; Andrew S. ; et al. | 2020-10-15 |
Process For The Preparation Of (s)-2-amino-non-8-enoic Acid
App 20200325506 - Abrahamson; Michael J. ; et al. | 2020-10-15 |
PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2- -TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF
App 20200317682 - ALLIAN; Ayman ; et al. | 2020-10-08 |
Anti-egfr Antibody Drug Conjugates (adc) And Uses Thereof
App 20200297863 - Reilly; Edward ; et al. | 2020-09-24 |
Protein Tyrosine Phosphatase Inhibitors And Methods Of Use Thereof
App 20200299246 - Halvorsen; Geoff T. ; et al. | 2020-09-24 |
Ectonucleotide Pyrophosphatase-phosphodiesterase 1 (enpp-1) Inhibitors And Uses Thereof
App 20200291024 - GALLATIN; William Michael ; et al. | 2020-09-17 |
Tetracyclic Bromodomain Inhibitors
App 20200291027 - Fidanze; Steven D. ; et al. | 2020-09-17 |
PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2- -TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF
App 20200291040 - ALLIAN; Ayman ; et al. | 2020-09-17 |
Glucocorticoid receptor agonist and immunoconjugates thereof
Grant 10,772,970 - Hobson , et al. Sept | 2020-09-15 |
Solid Pharmaceutical Compositions for Treating HCV
App 20200282004 - Sever; Nancy E. ; et al. | 2020-09-10 |
Tricyclic Quinoline And Quinoxaline Derivatives
App 20200283439 - Koolman; Hannes ; et al. | 2020-09-10 |
Anti-egfr Antibody Drug Conjugate Formulations
App 20200282072 - Tschoepe; Markus ; et al. | 2020-09-10 |
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20200277291 - Tao; Zhi-Fu ; et al. | 2020-09-03 |
Devices And Methods For Delivering A Beneficial Agent To A User
App 20200276385 - Hanagan; Ted ; et al. | 2020-09-03 |
Methods Of Administering Elagolix
App 20200268752 - Goss; Sandra L. ; et al. | 2020-08-27 |
Carbidopa Prodrugs
App 20200262852 - Cardinal-David; Benoit ; et al. | 2020-08-20 |
Systems and methods for tubing delivery
Grant 10,744,069 - Babbs , et al. A | 2020-08-18 |
Cylindrical pill dispenser and related methods of use
Grant 10,744,068 - Sita , et al. A | 2020-08-18 |
Therapeutic DLL4 Binding Proteins
App 20200255508 - Kind Code | 2020-08-13 |
Salts And Crystalline Forms Of An Apoptosis-inducing Agent
App 20200255425 - Kind Code | 2020-08-13 |
Bromodomain Inhibitors
App 20200255426 - Kind Code | 2020-08-13 |
Inhibitors Of Tyrosine Kinase 2 Mediated Signaling
App 20200255423 - Kind Code | 2020-08-13 |
Solid Pharmaceutical Compositions for Treating HCV
App 20200253968 - Kind Code | 2020-08-13 |
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20200253954 - Kind Code | 2020-08-13 |
Macrocyclic Mcl-1 Inhibitors And Methods Of Use
App 20200255451A1 - | 2020-08-13 |
Medication packaging and dispensing system
Grant 10,737,863 - Kim , et al. A | 2020-08-11 |
Antibody Drug Conjugates with Cell Permeable BCL-XL Inhibitors
App 20200246323 - Kind Code | 2020-08-06 |
BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the Same
App 20200246460 - Kind Code | 2020-08-06 |
Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2- -trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
Grant 10,730,883 - Allian , et al. | 2020-08-04 |
Salts and crystalline forms of an apoptosis-inducing agent
Grant 10,730,873 - Catron , et al. | 2020-08-04 |
Carbidopa prodrug
Grant 10,730,895 - Kym , et al. | 2020-08-04 |
BCL-XL Inhibitory Compounds and Antibody Drug Conjugates Including the Same
App 20200239553 - Ackler; Scott L. ; et al. | 2020-07-30 |
Macrocyclic Mcl-1 Inhibitors And Methods Of Use
App 20200239494A1 - | 2020-07-30 |
Apoptosis Inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20200231566A1 - | 2020-07-23 |
Pharmaceutical Compositions And Methods Of Use Thereof To Treat Pancreatic Enzyme Insufficiency
App 20200230064 - HALL; Jerry A. ; et al. | 2020-07-23 |
Salts And Crystalline Forms Of An Apoptosis-inducing Agent
App 20200231593 - Catron; Nathaniel ; et al. | 2020-07-23 |
Methods for Treating HCV
App 20200222397 - Collins; Christine ; et al. | 2020-07-16 |
Methods Of Treatment Using Selective Bcl-2 Inhibitors
App 20200222413 - Elmore; Steven ; et al. | 2020-07-16 |
ANTI-cMet ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USE
App 20200215200A1 - | 2020-07-09 |
Enzymatic processes for the preparation of (.+-.)-2-(difluoromethyl)-1-(alkoxycarbonyl)-cyclopropanecarboxylic acid and (.+-.)-2-(vinyl)-1-(alkoxycarbonyl)-cyclopropanecarboxylic acid
Grant 10,689,675 - Abrahamson , et al. | 2020-06-23 |
Anti-egfr Antibody Drug Conjugates (adc) And Uses Thereof
App 20200188525 - Reilly; Edward ; et al. | 2020-06-18 |
Container Cap and Method of Piercing a Seal Covering an Opening of a Container
App 20200189814 - Borgardt; Joy Elizabeth ; et al. | 2020-06-18 |
Methods of administering elagolix
Grant 10,682,351 - Goss , et al. | 2020-06-16 |
PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2- -TRIFLUOROETHYL)PYRR
App 20200181158 - ALLIAN; Ayman ; et al. | 2020-06-11 |
Medicine container, method of assembling the container, and method of dispensing the medicine from the container
Grant 10,675,218 - Upchurch , et al. | 2020-06-09 |
Macrocyclic MCL-1 inhibitors and methods of use
Grant 10,676,485 - Judd , et al. | 2020-06-09 |
Glucocorticoid receptor agonist and immunoconjugates thereof
Grant 10,668,167 - McPherson , et al. | 2020-06-02 |
Methods Of Treating Heavy Menstrual Bleeding
App 20200163965 - Chwalisz; Kristof ; et al. | 2020-05-28 |
Pharmaceutical Formulations for Subcutaneous Administration
App 20200155578 - Moussa; Ehab ; et al. | 2020-05-21 |
Anti-cd98 Antibodies And Antibody Drug Conjugates
App 20200147235 - Benatuil; Lorenzo ; et al. | 2020-05-14 |
Organic Reactions Carried Out In Aqueous Solution In The Presence Of A Hydroxyalkyl(alkyl)cellulose Or An Alkylcellulose
App 20200148610A1 - | 2020-05-14 |
Anti-B7-H3 antibodies and antibody drug conjugates
Grant 10,640,563 - Benatuil , et al. | 2020-05-05 |
Treatment Of Non-small Cell Lung Cancer
App 20200129482 - Ansell; Peter ; et al. | 2020-04-30 |
Bromodomain inhibitors
Grant 10,633,379 - Hasvold , et al. | 2020-04-28 |
Child-resistant medication container assembly
Grant D882,243 - Marshall , et al. | 2020-04-28 |
Anti-cd98 Antibodies And Antibody Drug Conjugates
App 20200121803 - Benatuil; Lorenzo ; et al. | 2020-04-23 |
Methods Of Administering Elagolix
App 20200121680 - Goss; Sandra L. ; et al. | 2020-04-23 |
Difluoroalkylcyclopropyl Amino Acids And Esters, And Syntheses Thereof
App 20200115329 - Lukin; Kirill A. ; et al. | 2020-04-16 |
Anti-cMet antibody drug conjugates and methods for their use
Grant 10,603,389 - Allan , et al. | 2020-03-31 |
Synthetic Route To Anti-viral Agents
App 20200095230 - Cink; Russell D. ; et al. | 2020-03-26 |
Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2- -trifluoroethyl)pyrrolidine-1-carb oxamide and solid state forms thereof
Grant 10,597,400 - Othman , et al. | 2020-03-24 |
Medication packaging combined with dispensing container
Grant D876,819 - Kim , et al. | 2020-03-03 |
2,2-difluoropropionamide Derivatives Of Bardoxolone Methyl, Polymorphic Forms And Methods Of Use Thereof
App 20200062800 - Sheikh; Ahmad Y. ; et al. | 2020-02-27 |
Container cap
Grant D876,226 - Marshall , et al. Feb | 2020-02-25 |
Bromodomain Inhibitors
App 20200048220 - Bogdan; Andrew ; et al. | 2020-02-13 |
Fused heterocyclic compounds as S1P modulators
Grant 10,556,907 - Lange , et al. Feb | 2020-02-11 |
Substituted isoxazolopyridazinones and isothiazolopyridazinones and methods of use
Grant 10,556,914 - Dinges , et al. Feb | 2020-02-11 |
Proline Amide Compounds And Their Azetidine Analogues Carrying A Specifically Substituted Benzyl Radical
App 20200039930A1 - | 2020-02-06 |
Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-A]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2- -trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
Grant 10,550,126 - Pangan , et al. Fe | 2020-02-04 |
Elagolix Sodium Compositions and Processes
App 20200024239A1 - | 2020-01-23 |
Enzymatic Process For The Preparation Of (1s,2r)-2-(difluoromethyl)-1-(propoxycarbonyl)cyclopropanecarboxylic Acid
App 20200024621A1 - | 2020-01-23 |
Methods of administering elagolix
Grant 10,537,572 - Goss , et al. Ja | 2020-01-21 |
Anti-A.beta. globulomer 4D10 antibodies
Grant 10,538,581 - Barghorn , et al. Ja | 2020-01-21 |
Macrocyclic MCL-1 Inhibitors and Methods of Use
App 20200010480A1 - | 2020-01-09 |
Processes for the preparation of (3S,4R)-3,ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2- -trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
Grant 10,519,164 - Allian , et al. Dec | 2019-12-31 |
Inhibitors of tyrosine kinase 2 mediated signaling
Grant 10,508,113 - Argiriadi , et al. Dec | 2019-12-17 |
Process for the preparation of (S)-2-amino-non-8-enoic acid
Grant 10,465,216 - Abrahamson , et al. No | 2019-11-05 |
Human single-chain T cell receptors
Grant 10,464,987 - Kranz , et al. No | 2019-11-05 |
Synthetic route to anti-viral agents
Grant 10,442,792 - Cink , et al. Oc | 2019-10-15 |
Difluoroalkylcyclopropyl amino acids and esters, and syntheses thereof
Grant 10,421,712 - Lukin , et al. Sept | 2019-09-24 |
Anti-cMet antibody drug conjugates and methods for their use
Grant 10,383,948 - Allan , et al. A | 2019-08-20 |
Container cap and method of piercing a seal covering an opening of a container
Grant 10,377,540 - Borgardt , et al. A | 2019-08-13 |
Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-#a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,- 2-trifluoroethyl)pyrrolidine-1-#carboxamide and solid state forms thereof
Grant 10,344,036 - Jayanth , et al. July 9, 2 | 2019-07-09 |
Salt and crystalline forms thereof of a drug
Grant 10,329,276 - Zhang , et al. | 2019-06-25 |
High purity oritavancin and method of producing same
Grant 10,328,118 - Rafai Far , et al. | 2019-06-25 |
Monoclonal antibodies against amyloid beta protein and uses thereof
Grant 10,323,084 - Hillen , et al. | 2019-06-18 |
Enzymatic process for the preparation of (1S,2R)-2-(difluoromethyl)-1-(propoxycarbonyl)cyclopropanecarboxylic acid
Grant 10,316,338 - Abrahamson , et al. | 2019-06-11 |
Inhibitor compounds of phosphodiesterase type 10A
Grant 10,308,610 - Geneste , et al. | 2019-06-04 |
Automatic injection device with near-field communication
Grant 10,300,200 - Hughes , et al. | 2019-05-28 |
Method for treating HCV
Grant 10,286,029 - Awni , et al. | 2019-05-14 |
Heterocyclic kinase inhibitors
Grant 10,280,184 - Friedman , et al. | 2019-05-07 |
Indazolones as modulators of TNF signaling
Grant 10,273,238 - Breinlinger , et al. | 2019-04-30 |
Tricyclic modulators of TNF signaling
Grant 10,266,532 - Breinlinger , et al. | 2019-04-23 |
Systems and methods for morphology analysis
Grant 10,269,117 - Matayoshi , et al. | 2019-04-23 |
Treatment of filarial diseases
Grant 10,238,677 - Von Geldern , et al. | 2019-03-26 |
Pump, motor and assembly for beneficial agent delivery
Grant 10,232,111 - Anderson , et al. | 2019-03-19 |
Thiazoles and uses thereof
Grant 10,233,179 - Ng , et al. | 2019-03-19 |
Solid dispersions containing an apoptosis-inducing agent
Grant 10,213,433 - Catron , et al. Feb | 2019-02-26 |
Devices and methods for delivering a beneficial agent to a user
Grant 10,213,546 - Anderson , et al. Feb | 2019-02-26 |
Monoclonal antibodies against amyloid beta protein and uses thereof
Grant 10,208,109 - Hillen , et al. Feb | 2019-02-19 |
Compositions and methods for treating HCV
Grant 10,201,584 - Collins , et al. Feb | 2019-02-12 |
Formulations of pyrimidinedione derivative compounds
Grant 10,201,542 - Li , et al. Feb | 2019-02-12 |
Compositions and methods for treating HCV
Grant 10,201,541 - Collins , et al. Feb | 2019-02-12 |
Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-.alpha.]pyrrolo[2,3-e]-pyrazin-8-yl)-N-- (2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
Grant 10,202,393 - Jayanth , et al. Feb | 2019-02-12 |
Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2- -trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
Grant 10,202,394 - Jayanth , et al. Feb | 2019-02-12 |
Sealing arrangement for syringe
Grant 10,195,350 - Gibler , et al. Fe | 2019-02-05 |
Tricyclic compounds
Grant RE47,221 - Wishart , et al. Fe | 2019-02-05 |
Anti-huLRRC15 antibody drug conjugates and methods for their use
Grant 10,195,209 - Gish , et al. Fe | 2019-02-05 |
Medication packaging and dispensing system
Grant D839,584 - Kim , et al. Fe | 2019-02-05 |
| 